References
Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R, for GESICA. Randomized trial of low-dose amiodarone in severe heart failure. Lancet 1994;344:493-498.
Singh SN, Fletcher RD, Fisher SG, et al., for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995;333:77-82.
Nul DR, Doval HC, Grancelli HO, et al., on behalf of the GESICA-GEMA investigators. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997;29:1199-1205.
Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6,500 patients in randomized trials. Lancet 1997;350:1417-1424.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Doval, H.C. Clinical Implications of the CAMIAT, EMIAT and SWORD Trials: A South American Perspective. Card Electrophysiol Rev 2, 36–37 (1998). https://doi.org/10.1023/A:1009938306576
Issue Date:
DOI: https://doi.org/10.1023/A:1009938306576